IDEAYA Biosciences, Inc.

NASDAQ:IDYA

Biotechnology

Healthcare
$26.17 -1.45%

-$0.45 today

Market cap
$2.53B
Beta
-0.05
P/E (TTM)
-19.5
EPS (TTM)
-$1.58
52W Low $20.50High $39.28

Volume 1.42M

Average 1.44M

Balance Sheet

Inspect the capital base behind the business.

Assets

$1.11B

FY 2025 · Annual

-1.3% YoY

Liabilities

$86.39M

FY 2025 · Annual

+33.0% YoY

Equity

$1.02B

FY 2025 · Annual

-3.4% YoY

Balance Sheet

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Cash & Equivalents92.05M68.63M157.02M84.38M112.83M
Short-term Investments154.72M296.2M368.1M591.94M526.56M
Net Receivables1.1M211K18K3K5.97M
Inventory00000
Other Current Assets05.41M7.5M13.39M21.37M
Total Current Assets251M370.45M532.63M689.71M666.73M
Property, Plant & Equipment (Net)8.66M8.99M8.41M27.74M31.29M
Goodwill00000
Intangible Assets00000
Long-term Investments121.29M8.32M107.49M405.83M410.3M
Tax Assets00000
Other Non-current Assets397K205K782K805K1.02M
Total Non-current Assets130.35M17.52M116.68M434.38M442.6M
Total Assets381.35M387.97M649.32M1.12B1.11B
Account Payables2.1M4.28M6.6M15.42M17.58M
Short-term Debt0000339K
Tax Payables00000
Deferred Revenue29.04M8.57M000
Other Current Liabilities0011.78M30.35M29.69M
Total Current Liabilities45.16M31.72M27.1M46.07M58.82M
Long-term Debt000027.58M
Deferred Tax Liabilities00000
Deferred Revenue (Non-current)31.19M5.19M000
Other Non-current Liabilities00000
Total Non-current Liabilities34.67M6.8M1.13M18.87M27.58M
Total Liabilities79.83M38.51M28.23M64.94M86.39M
Common Stock4K5K7K9K9K
Retained Earnings(176.75M)(235.4M)(348.36M)(622.84M)(736.54M)
Accumulated OCI(712K)(2.87M)562K812K2.27M
Other Stockholders Equity00000
Minority Interest00000
Total Equity301.51M349.46M621.09M1.06B1.02B
Total Debt5.18M3.48M2.87M19.17M27.91M
Net Debt(86.87M)(65.15M)(154.15M)(65.21M)(84.91M)

Balance Sheet

Assets, liabilities & equity

Cash & Equivalents$157.5M
Short-term Investments$513.7M
Receivables$6.6M
Other Current$18.3M
Total Current Assets$696.1M
PP&E (Net)$31.2M
Long-term Investments$301.7M
Other Non-current$1.3M
Total Non-current Assets$334.2M
Total Assets$1.0B

Analysis

Selected assets total $1.0B for Latest. The largest visible component is Short-term Investments at $513.7M, about 49.9% of the tab total. Use the mix to judge balance sheet concentration, liquidity, leverage, and how much of book value is supported by tangible operating assets.

Recent Filings

Recent regulatory filings

FilingDescriptionDate
S-8S-8 filingNov 3, 2026
8-KCurrent reportNov 3, 2026
10-QQuarterly reportNov 3, 2026
4Statement of changes in beneficial ownershipOct 8, 2026
SC 13GSC 13G filingAug 14, 2026

How much cash does IDYA have?

IDEAYA Biosciences, Inc. (IDYA) reported $112.83M in cash and equivalents in fiscal 2025.

How much debt does IDYA carry?

IDEAYA Biosciences, Inc. (IDYA) reported $27.91M of total debt, with net debt of -$84.91M.